Skip to Main Content
Yale Center for Clinical Investigation
YSM Home

INFORMATION FOR

COVID-19 Outpatient, Phase COVID-I

Topical Antibacterial Agents for Prevention of COVID-19

What is the purpose of this trial?

The primary objective of this study is to determine whether intranasal application of aminoglycoside (Neosporin) increases local nasal innate immune responses compared to placebo control in healthy participants.

  • Trial with
    Bill and Melinda Gates Foundation
  • Ages
    18 years - 60 years
  • Gender
    Both
Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Lindsey Fraczkiewicz

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

  • Last Updated
    03/24/2023
  • Study HIC
    #2000032248

Contact Information

For more information about this study, including how to volunteer, contact Lindsey Fraczkiewicz